Exelon Corp (EXC) Financial Statements

Exelon's financial health presents a mixed but ultimately concerning picture when assessed against the GoodMoat Quality Indicators. The company shows strength in operating profitability, with an operating margin of 21.2%, which is solid for a regulated utility. However, several key quality metrics are weak. Most critically, the free cash flow (FCF) yield is negative at -4.7%, indicating the company is not generating surplus cash for shareholders after capital expenditures. This fails the framework's threshold for positive, growing FCF with a margin above 10-15%. The balance sheet is also a significant concern, with a debt-to-equity ratio of 1.74, which is well above the favourable level of less than 1.0x Debt/EBITDA implied by the framework. This high leverage introduces financial risk. Revenue growth is negative at -1.1% YoY, which is a weak indicator and does not support a favourable growth assessment. While the ROE of 9.6% is positive, it falls below the framework's high-quality benchmark of 15-20%. The dividend yield of 3.36% provides some income, but the overarching financial profile is defined by high debt and cash consumption, which outweigh the stable operating margins. Analysis based on data as of 2024-05-15.